MAPK9 and depressive symptom measurement: The possibility of such influence has already been described: some anti-depression drugs that were used in anatomical models of “sickness behavior” and in human depression clinical trials were shown to suppress the clinical markers of inflammation, as well as SAPK/MAPK and/or JAK/STAT signaling in vitro [127].